Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong
· Delayed Price · Currency is HKD 3.380
+0.040 (1.20%)
Apr 29, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1,092 | 1,140 | 1,461 | 490.63 | 675.24 | Upgrade
|
| Cash & Short-Term Investments | 1,092 | 1,140 | 1,461 | 490.63 | 675.24 | Upgrade
|
| Cash Growth | -4.16% | -21.98% | 197.74% | -27.34% | -34.58% | Upgrade
|
| Accounts Receivable | 74.83 | 34.39 | 0.98 | 12.94 | - | Upgrade
|
| Other Receivables | 4.78 | 22.18 | 15.81 | 408.96 | 9.7 | Upgrade
|
| Receivables | 79.61 | 56.57 | 16.79 | 421.9 | 9.7 | Upgrade
|
| Inventory | 121.85 | 126.7 | 67.87 | 18.46 | - | Upgrade
|
| Prepaid Expenses | 1.45 | - | - | - | - | Upgrade
|
| Other Current Assets | 1.24 | 13.48 | 27 | 9.27 | 19.66 | Upgrade
|
| Total Current Assets | 1,296 | 1,336 | 1,572 | 940.26 | 704.6 | Upgrade
|
| Property, Plant & Equipment | 110.07 | 129.66 | 114.54 | 139.71 | 156.6 | Upgrade
|
| Other Intangible Assets | 22.59 | 26.07 | 28.57 | 31.95 | 9.03 | Upgrade
|
| Other Long-Term Assets | 40.65 | 35.07 | 9.79 | 9.58 | 33.33 | Upgrade
|
| Total Assets | 1,470 | 1,527 | 1,725 | 1,121 | 903.55 | Upgrade
|
| Accounts Payable | 81.65 | 63.72 | 51.63 | 20.98 | 23.79 | Upgrade
|
| Accrued Expenses | 60.38 | 37.9 | 37.17 | 38.37 | 32.15 | Upgrade
|
| Short-Term Debt | - | - | - | 33.92 | - | Upgrade
|
| Current Portion of Long-Term Debt | 30.61 | 98.28 | 17.19 | - | - | Upgrade
|
| Current Portion of Leases | 18.05 | 17.26 | 24.28 | 21.49 | 13.3 | Upgrade
|
| Current Unearned Revenue | - | 98.04 | 98.38 | 53.86 | 13.85 | Upgrade
|
| Other Current Liabilities | 19.58 | 15.07 | 23.38 | 19.76 | 23.8 | Upgrade
|
| Total Current Liabilities | 210.27 | 330.27 | 252.03 | 188.39 | 106.88 | Upgrade
|
| Long-Term Debt | 220.56 | 138.74 | 106.84 | - | - | Upgrade
|
| Long-Term Leases | 32.46 | 45.91 | 19.44 | 42.17 | 58.23 | Upgrade
|
| Long-Term Unearned Revenue | - | 1,148 | 1,246 | 611.36 | 288.11 | Upgrade
|
| Total Liabilities | 463.28 | 1,663 | 1,624 | 841.92 | 453.22 | Upgrade
|
| Common Stock | 7.22 | 7.21 | 7.21 | 7.21 | 7.21 | Upgrade
|
| Additional Paid-In Capital | - | 5,932 | 5,931 | 5,922 | 5,910 | Upgrade
|
| Retained Earnings | - | -6,361 | -6,111 | -5,900 | -5,696 | Upgrade
|
| Treasury Stock | -0.41 | -0.49 | -0.51 | -0.58 | -0.63 | Upgrade
|
| Comprehensive Income & Other | 999.64 | 286.43 | 274.5 | 250.96 | 229.63 | Upgrade
|
| Total Common Equity | 1,006 | -135.47 | 101.15 | 279.58 | 450.33 | Upgrade
|
| Shareholders' Equity | 1,006 | -135.47 | 101.15 | 279.58 | 450.33 | Upgrade
|
| Total Liabilities & Equity | 1,470 | 1,527 | 1,725 | 1,121 | 903.55 | Upgrade
|
| Total Debt | 301.67 | 300.18 | 167.75 | 97.58 | 71.53 | Upgrade
|
| Net Cash (Debt) | 790.62 | 839.57 | 1,293 | 393.05 | 603.71 | Upgrade
|
| Net Cash Growth | -5.83% | -35.07% | 228.98% | -34.89% | -36.54% | Upgrade
|
| Net Cash Per Share | 0.79 | 0.86 | 1.32 | 0.41 | 0.63 | Upgrade
|
| Filing Date Shares Outstanding | 991.23 | 983.66 | 980.52 | 970.11 | 963.55 | Upgrade
|
| Total Common Shares Outstanding | 991.23 | 983.66 | 980.52 | 970.11 | 963.55 | Upgrade
|
| Working Capital | 1,086 | 1,006 | 1,320 | 751.87 | 597.72 | Upgrade
|
| Book Value Per Share | 1.02 | -0.14 | 0.10 | 0.29 | 0.47 | Upgrade
|
| Tangible Book Value | 983.86 | -161.53 | 72.58 | 247.63 | 441.31 | Upgrade
|
| Tangible Book Value Per Share | 0.99 | -0.16 | 0.07 | 0.26 | 0.46 | Upgrade
|
| Machinery | - | 27.33 | 25.49 | 23.46 | 21.61 | Upgrade
|
| Construction In Progress | - | 24.54 | 22.4 | 21.3 | 18.92 | Upgrade
|
| Leasehold Improvements | - | 44.15 | 43.88 | 43.33 | 40.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.